English

Computational Study of Thermosensitivity of Liposomes Modulated by Leucine Zipper-Structured Lipopeptides

• XU Xiejun ^1, ,
• XIAO Xingqing ^{2, ,} ,
• XU Shouhong ^1, ,
• LIU Honglai ^{1, ,}

• 1.

  State Key Laboratory of Chemical Engineering, College of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai 200237, P. R. China

• 2.

  Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC 27695-7905, USA

Corresponding author: XIAO Xingqing, Email: xxiao3@ncsu.edu; Tel.: +1-984-255-3418; LIU Honglai, Email: hlliu@ecust.edu.cn; Tel.: +86-21-64252921

• Received Date: 19 June 2018
  Accepted Date: 11 July 2018
  Revised Date: 11 July 2018
  Available Online: 15 June 2019
• Fund Project:

  The project was supported by the National Natural Science Foundation of China (21776071), the National Natural Science Foundation of China for Innovative Research Groups (51621002) and the 111 Project of China (B08021)

Abstract: Leucine zipper-functionalized liposomes are promising drug carriers for cancer treatment because of their unique thermosensitivity. The leucine zippers, which consist of two α-helical polypeptides that dimerize in parallel, have characteristic heptad repeats (represented by [abcdefg]_n). A leucine residue was observed periodically at site "d" to stabilize the dimerization of the two polypeptides through inter-chain hydrophobic interactions. As the temperature increased, the inter-chain hydrophobic interactions became weaker, eventually triggering the dissociation of the leucine zippers. Due to the unique nature of the temperature response, leucine zippers are useful for developing novel lipid-peptide vesicles for drug delivery because they allow for better control and optimization of drug release under mild hyperthermia. The base sequence of the leucine zipper peptides used in our lab for the functionalize liposomal carrier is [VAQLEVK-VAQLESK-VSKLESK-VSSLESK]. Our recent experiments revealed that modifying this peptide at the N-terminus with distinct functional groups can change the physicochemical properties of the lipopeptides, and eventually affect the liposomes' phase transition behaviors. Four leucine zipper-structured lipopeptides with distinct head groups, viz. ALA, C3CO, C5CO, and POCH, were studied computationally to examine the influence of the molecular structures on the phase transition behaviors of lipopeptides. A series of computational techniques including quantum mechanics (QM) calculations, implicit solvation replica exchange molecular dynamics (REMD) simulations, dihedral principal component analysis (dPCA), and dictionary of protein secondary structure (DSSP) methods, and the conventional explicit solvation molecular dynamics (MD) simulations were applied in this work. First, QM calculations were conducted to obtain the partial charges of some modified head groups. Implicit-solvent REMD simulations were then performed to study the effect of temperature on the folded conformations of the leucine zipper peptides. The dPCA method was used to simulate trajectories to identify representative structures of the peptides at various temperatures, and the DSSP method was used to determine conformation transitions of the four lipopeptides ALA, C3CO, C5CO, and POCH at 324.8, 312.1, 319.1, and 319.4 K, respectively. The thermostability of the lipopeptide dimers in the lipid DPPC bilayer was studied in the conventional explicit solvent MD simulations. Finally, we conducted a deep analysis on the area per lipid and the electron-density profile for the DPPC bilayer to explore the folding and unfolding processes of the lipopeptides in the liposomes to better understand the underlying phase transition mechanisms of the thermosensitive liposomes. On this basis, we could further improve the thermosensitivity of the leucine zipper-structured lipopeptides, thereby facilitating the development of liposomal drug delivery techniques in the future.

Key words:
• Leucine zipper-structured lipopeptides
•  /  Thermosensitive liposomes
•  /  Cancer therapy
•  /  Drug carrier
•  /  Molecular dynamics simulation

• 1. [1]

     Aschenbrenner, D. S. Am. J. Nurs. 2017, 117, 22. doi: 10.1097/01.NAJ.0000521967.00600.3a

  2. [2]

     Liehr, T. Eur. J. Hum. Genet. 2017, 25, 902. doi: 10.1038/ejhg.2017.7

  3. [3]

     Lokerse, J. M.; Eggermont, M. M.; Grüll, H.; Koning, G. A. J. Controll. Release 2018, 270, 282. doi: 10.1016/j.jconrel.2017.12.012

  4. [4]

     Mura, P.; Matascia, N.; Nativi, C.; Richichi, B. Eur. J. Pharm. Biopharm. 2018, 122, 54. doi: 10.1016/j.ejpb.2017.10.008

  5. [5]

     Malaescu, I.; Fannin, P. C.; Marin, C. N.; Lazic, D. Med. Hypotheses 2018, 110, 76. doi: 10.1016/j.mehy.2017.11.004

  6. [6]

     Al-Ahmady, Z. S.; Al-Jamal, W. T.; Bossche, J. V.; Bui, T. T.; Drake, A. F.; Mason, A. J.; Kostarelos, K. ACS Nano 2012, 6, 9335. doi: 10.1021/nn302148p

  7. [7]

     Srinivasan, M.; Lahiri, D. K. Mol. Neurobiol. 2017, 54, 8063. doi: 10.1007/s12035-016-0277-5

  8. [8]

     Roodbarkelari, F.; Groot, E. P. New Phytol. 2017, 213, 95. doi: 10.1111/nph.14132

  9. [9]

     Wang, S. J.; Shen, Y. X.; Zhang, J. Q.; Xu, S. H.; Liu, H. L. Phys. Chem. Chem. Phys. 2016, 18, 10129. doi: 10.1039/C6CP00378H

  10. [10]

      Wang, S. J.; Han, X.; Liu, D. Y.; Li, M. Y.; Xu, S. H.; Liu, H. L. Langmuir 2017, 33, 1478. doi: 10.1021/acs.langmuir.6b04080

  11. [11]

      王斯佳, 李梦雅, 徐首红, 刘洪来.物理化学学报, 2017, 33, 829. doi: 10.3866/PKU.WHXB201701062Wang, S. J.; Li, M. Y.; Xu, S. H.; Liu, H. L. Acta Phys. -Chim. Sin. 2017, 33, 829. doi: 10.3866/PKU.WHXB201701062

  12. [12]

      Xu, X. X.; Xiao, X. Q.; Xu, S. H.; Liu, H. L. Phys. Chem. Chem. Phys. 2016, 18, 25465. doi: 10.1039/C6CP05145F

  13. [13]

      Cornell, W. D.; Cieplak, P.; Bayly, C. I.; Kollmann, P. A. J. Am. Chem. Soc. 1993, 115, 9620. doi: 10.1021/ja00074a030

  14. [14]

      Cornell, W. D.; Cieplak, P.; Bayly, C. I.; Gould, I. R.; Merz, K. M.; Ferguson, D. M.; Spellmeyer, D. C.; Fox, T.; Caldwell, J. W.; Kollman, P. A. J. Am. Chem. Soc. 1995, 117, 5179. doi: 10.1021/ja00124a002

  15. [15]

      Cieplak, P.; Cornell, W. D.; Bayly, C. I.; Kollmann, P. A. J. Comput. Chem. 1995, 16, 1357. doi: 10.1002/jcc.540161106

  16. [16]

      Abraham, M. J.; Murtola, T.; Schulz, R.; Pll, S.; Smith, J. C.; Hess, B.; Lindahl, E. SoftwareX 2015, 1–2, 19. doi: 10.1016/j.softx.2015.06.001

  17. [17]

      Pronk, S.; Pall, S.; Schulz, R.; Larsson, P.; Bjelkmar, P.; Apostolov, R.; Shirts, M. R.; Smith, J. C.; Kasson, P. M.; van der Spoel, D.; et al. Bioinformatics 2013, 29, 845. doi: 10.1093/bioinformatics/btt055

  18. [18]

      Maier, J.; Martinez, C.; Kasavajhala, K.; Wickstrom, L.; Hauser, K.; Simmerling, C. J. Chem. Theory Comput. 2015, 11, 3696. doi: 10.1021/acs.jctc.5b00255

  19. [19]

      Onufriev, A.; Bashford, D.; Case, D. A. Proteins: Struct., Funct., Bioinf. 2004, 55, 383. doi: 10.1002/prot.20033

  20. [20]

      Martínez, L.; Andrade, R.; Birgin, E. G.; Martínez, J. M. J. Comput. Chem. 2009, 30, 2157. doi: 10.1002/jcc.21224

  21. [21]

      Martínez, J. M.; Martínez, L. J. Comput. Chem. 2003, 24, 819. doi: 10.1002/jcc.10216

  22. [22]

      Biasini, M.; Bienert, S.; Waterhouse, A.; Arnold, K.; Studer, G.; Schmidt, T.; Kiefer, F.; Cassarino, T. G.; Bertoni, M.; Bordoli, L.; et al. Nucleic Acids Res. 2014, 42, 252. doi: 10.1093/nar/gku340

  23. [23]

      Kiefer, F.; Arnold, K.; Künzli, M.; Bordoli, L.; Schwede, T. Nucleic Acids Res. 2009, 37, 387. doi: 10.1093/nar/gkn750

  24. [24]

      Arnold, K.; Bordoli, L.; Kopp, J.; Schwede, T. Bioinformatics 2006, 22, 195. doi: 10.1093/bioinformatics/bti770

  25. [25]

      Dickson, C. J.; Madej, B. D.; Skjevik, A. A.; Betz, R. M.; Teigen, K.; Gould, I. R.; Walker, R. C. J. Chem. Theory Comput. 2014, 10, 865. doi: 10.1021/ct4010307

  26. [26]

      Jorgensen, W. L.; Chandrasekhar, J.; Madura, J. D.; Impey, R. W.; Klein, M. L. J. Chem. Phys. 1983, 79, 926. doi: 10.1063/1.445869

  27. [27]

      Altis, A.; Nguyen, P. H.; Hegger, R.; Stock, G. J. Chem. Phys. 2007, 126, 244111. doi: 10.1063/1.2746330

  28. [28]

      Borgohain, G.; Paul, S. Mol. Simul. 2017, 43, 52. doi: 10.1080/08927022.2016.1233546

  29. [29]

      Kabsch, W.; Sander, C. Biopolymers 1983, 22, 2577. doi: 10.1002/bip.360221211

•